F. Oberti

4.1k total citations · 1 hit paper
65 papers, 2.8k citations indexed

About

F. Oberti is a scholar working on Epidemiology, Hepatology and Pathology and Forensic Medicine. According to data from OpenAlex, F. Oberti has authored 65 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Epidemiology, 45 papers in Hepatology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in F. Oberti's work include Liver Disease Diagnosis and Treatment (57 papers), Liver Disease and Transplantation (27 papers) and Hepatitis C virus research (13 papers). F. Oberti is often cited by papers focused on Liver Disease Diagnosis and Treatment (57 papers), Liver Disease and Transplantation (27 papers) and Hepatitis C virus research (13 papers). F. Oberti collaborates with scholars based in France, United States and Switzerland. F. Oberti's co-authors include Paul Calès, Christophe Aubé, Christophe Pilette, Yves Gallois, Dominique Guyader, Véronique Sebille, Damien Olivié, Yves Deugnier, Y. Gandon and Pierre Bédossa and has published in prestigious journals such as The Lancet, JAMA and Gastroenterology.

In The Last Decade

F. Oberti

65 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Non-invasive assessment of hepatic iron stores by MRI

2004 502 citations Y. Gandon, Damien Olivié et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F. Oberti France	24	2.1k	1.5k	455	365	344	65	2.8k
R. Hultcrantz Sweden	26	1.1k 0.5×	1.1k 0.8×	384 0.8×	178 0.5×	104 0.3×	62	2.6k
Melanie Beaton Canada	20	1.3k 0.7×	684 0.5×	89 0.2×	169 0.5×	141 0.4×	41	1.9k
Gemino Fiorelli Italy	32	1.1k 0.5×	764 0.5×	207 0.5×	1.3k 3.5×	1.0k 3.0×	81	3.1k
Cristina Rigamonti Italy	23	1.6k 0.8×	1.3k 0.9×	301 0.7×	73 0.2×	79 0.2×	69	2.1k
Pierre Deltenre Belgium	34	3.2k 1.6×	2.3k 1.5×	1.3k 2.9×	108 0.3×	86 0.3×	123	4.3k
Archana Rastogi India	28	1.2k 0.6×	1.2k 0.8×	233 0.5×	82 0.2×	67 0.2×	168	2.5k
Axel Balian France	21	1.1k 0.5×	485 0.3×	503 1.1×	83 0.2×	34 0.1×	41	1.9k
Urmila Khettry United States	27	1.1k 0.6×	1.1k 0.7×	712 1.6×	54 0.1×	53 0.2×	76	2.8k
Gian Ludovico Rapaccini Italy	28	1.3k 0.6×	1.4k 1.0×	158 0.3×	66 0.2×	65 0.2×	112	2.7k
Marie Christine Rousselet France	19	1.1k 0.5×	956 0.6×	216 0.5×	54 0.1×	121 0.4×	28	1.5k

Countries citing papers authored by F. Oberti

Since Specialization

Citations

This map shows the geographic impact of F. Oberti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Oberti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Oberti more than expected).

Fields of papers citing papers by F. Oberti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Oberti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Oberti. The network helps show where F. Oberti may publish in the future.

Co-authorship network of co-authors of F. Oberti

This figure shows the co-authorship network connecting the top 25 collaborators of F. Oberti. A scholar is included among the top collaborators of F. Oberti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Oberti. F. Oberti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boursier, Jérôme, Clémence M. Canivet, Charlotte Costentin, et al.. (2022). Impact of Type 2 Diabetes on the Accuracy of Noninvasive Tests of Liver Fibrosis With Resulting Clinical Implications. Clinical Gastroenterology and Hepatology. 21(5). 1243–1251.e12. 51 indexed citations

Paisant, Anita, Adrien Lannes, Julien Chaigneau, et al.. (2021). Liver fibrosis staging by computed tomography: Prospective randomized multicentric evaluation of image analyses. Clinics and Research in Hepatology and Gastroenterology. 46(2). 101797–101797. 3 indexed citations

Bardou‐Jacquet, Edouard, Bruno Turlin, Sophie Michalak, et al.. (2021). Transient Elastography Accurately Screens for Compensated Advanced Chronic Liver Disease in Patients With Ongoing or Recent Alcohol Withdrawal. Clinical Gastroenterology and Hepatology. 20(7). 1542–1552.e6. 20 indexed citations

Boursier, Jérôme, et al.. (2015). Screening for significant chronic liver disease by using three simple ultrasound parameters. European Journal of Radiology. 84(8). 1466–1472. 5 indexed citations

Boursier, Jérôme, Charlène Brochard, Sandrine Bertrais, et al.. (2014). Combination of blood tests for significant fibrosis and cirrhosis improves the assessment of liver‐prognosis in chronic hepatitis C. Alimentary Pharmacology & Therapeutics. 40(2). 178–188. 33 indexed citations

Calès, Paul, et al.. (2014). Cirrhosis Diagnosis and Liver Fibrosis Staging. Journal of Clinical Gastroenterology. 49(6). 512–519. 7 indexed citations

Boursier, Jérôme, Victor de Lédinghen, Vincent Leroy, et al.. (2010). 1046 A NEW FIBROSIS STAGING METHOD PROVIDES VERY ACCURATE NON-INVASIVE DIAGNOSIS OF LIVER FIBROSIS WITHOUT LIVER BIOPSY. Journal of Hepatology. 52. S405–S405. 1 indexed citations

Calès, Paul, Jérôme Boursier, Julien Chaigneau, F. Oberti, & M.C. Rousselet. (2009). Treatment of liver fibrosis: Clinical aspects. Gastroentérologie Clinique et Biologique. 33(10-11). 958–966. 7 indexed citations

Lédinghen, Victor de, Vlad Ratziu, Xavier Causse, et al.. (2006). Diagnostic and predictive factors of significant liver fibrosis and minimal lesions in patients with persistent unexplained elevated transaminases. A prospective multicenter study. Journal of Hepatology. 45(4). 592–599. 56 indexed citations

10.

Gandon, Y., Damien Olivié, Dominique Guyader, et al.. (2004). Non-invasive assessment of hepatic iron stores by MRI. The Lancet. 363(9406). 357–362. 502 indexed citations breakdown →

11.

Michalak, Sophie, Marie‐Christine Rousselet, Pierre Bédossa, et al.. (2003). Respective roles of porto‐septal fibrosis and centrilobular fibrosis in alcoholic liver disease. The Journal of Pathology. 201(1). 55–62. 50 indexed citations

12.

Moal, Frédéric, Daniel Chappard, Jianhua Wang, et al.. (2002). Fractal dimension can distinguish models and pharmacologic changes in liver fibrosis in rats. Hepatology. 36(4). 840–849. 43 indexed citations

13.

Pilette, Christophe, F. Oberti, Nary Veal, et al.. (1999). Long-term administration of PGE1 increases liver fibrosis and collateral blood flow in bile-duct-ligated rats. Journal of Hepatology. 30(1). 70–76. 11 indexed citations

14.

Aubé, Christophe, F. Oberti, D. Loisel, et al.. (1999). Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis. Journal of Hepatology. 30(3). 472–478. 201 indexed citations

15.

Oberti, F., Nary Veal, Mehdi Kaassis, et al.. (1998). Hemodynamic effects of terlipressin and octreotide administration alone or in combination in portal hypertensive rats. Journal of Hepatology. 29(1). 103–111. 20 indexed citations

16.

Oberti, F., Christophe Pilette, Nary Veal, et al.. (1998). Antifibrotic and Hemodynamic Effects of the Early and Chronic Administration of Octreotide in Two Models of Liver Fibrosis in Rats. Hepatology. 28(6). 1525–1531. 52 indexed citations

17.

Pilette, Christophe, Nary Veal, F. Oberti, et al.. (1998). Effects of long-term administration of interferon α in two models of liver fibrosis in rats. Journal of Hepatology. 29(2). 263–270. 55 indexed citations

18.

Pilette, Christophe, Marie Christine Rousselet, Pierre Bédossa, et al.. (1998). Histopathological evaluation of liver fibrosis: quantitative image analysis vs semi-quantitative scores. Journal of Hepatology. 28(3). 439–446. 163 indexed citations

19.

Burtin, Pascal, Bruno Bour, A Blanchi, et al.. (1997). Endoscopic detection of early esophageal cancer in a high-risk population: does Lugol staining improve videoendoscopy?. Gastrointestinal Endoscopy. 45(6). 480–484. 66 indexed citations

20.

Oberti, F., Christophe Pilette, Rousselet Mc, et al.. (1997). Noninvasive diagnosis of hepatic fibrosis or cirrhosis. Gastroenterology. 113(5). 1609–1616. 285 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact